#China #Shanghai #AI Innovation #Medical Imaging #United Imaging

United Imaging Healthcare Reports 2024 Financial Highlights

United Imaging Healthcare, a prominent player in the field of advanced medical imaging and radiotherapy equipment, has unveiled its financial performance for 2024 alongside results for the first quarter of 2025. This announcement cements its status as a leader in innovation and global reach within the medical technology sector.

Financial Performance

In their 2024 annual report, United Imaging Healthcare highlighted a remarkable revenue figure of CNY 10.30 billion. The net income attributable to shareholders stood at CNY 1.26 billion, showcasing a robust financial year for the company. As for the first quarter of 2025, the company registered a revenue of CNY 2.48 billion, with net income reaching CNY 0.37 billion. These figures illustrate a year-over-year growth of 5.42% in revenue and 1.87% in net income, emphasizing the company's upward trajectory in the market.

Commitment to Innovation

United Imaging is dedicated to continuous innovation, reflecting this in its research and development investments which amounted to CNY 2.26 billion in 2024—an increase of 17.84% from the previous year. This investment has led to the launch of over 140 innovative products globally by the end of 2024, with 49 products receiving FDA clearance through the 510(k) process and 46 achieving CE certification. Notable products include the uMI Panorama series which completed CE certification and the uMR Jupiter, acclaimed as the only whole-body clinical ultra-high-field MRI system globally to obtain approvals from the NMPA, FDA, and CE.

The company's advancements in AI integration into radiology have not gone unnoticed, with over 20 AI-powered devices securing FDA approval, reinforcing United Imaging's leadership in the field.

Global Expansion Strategy

The past year has seen United Imaging accelerate its globalization strategy, significantly expanding its sales and service networks across established and emerging markets. Presently, the company operates in more than 85 countries and regions, servicing over 200 cities worldwide. With a solid global service framework consisting of seven regional spare parts hubs and 32 national warehouses, the company reported overseas revenue of CNY 2.27 billion in 2025—a notable year-over-year increase of 35.07%.

European Ventures

In Europe, the establishment of a regional headquarters in Rotterdam, the Netherlands, has paved the way for commercial deployments in the five largest Western European economies: the UK, France, Germany, Italy, and Spain. Their advanced light-guide digital PET/CT systems have been successfully implemented in leading medical facilities, such as the EVESIO Nuclear Medical Center in France and the Kliniken Essen-Mitte Evang in Germany.

By the end of 2024, United Imaging achieved impressive market penetration across more than half of the 27 EU member states, forging a robust installed base in 15+ countries.

North American Success

In North America, United Imaging's complete suite of imaging products has garnered significant coverage, exceeding 70% of U.S. state-level administrative regions. With a cumulative of over 100 PET/CT installations in prominent clinical and research establishments like Yale University and the University of California, Davis, the company continues to solidify its reputation in the competitive landscape.

Future Outlook

Looking forward, United Imaging Healthcare is focused on leveraging its innovative momentum to enhance healthcare delivery globally. The company aims to usher in a new era of cutting-edge technologies dedicated to improving clinical outcomes and ensuring quality healthcare accessibility for patients worldwide. As they navigate the future, United Imaging remains committed to their principles of growth, innovation, and excellence in the field of medical imaging.

Through strategic global expansions and a strong emphasis on AI solutions, United Imaging Healthcare is setting the stage for a transformative impact in the medical technology domain, confirming its place as a leader in healthcare innovation.